Cannabis & Medicinal Research

This session explores the application of cannabis-based medicines for chronic pain relief, a leading area of therapeutic interest. Topics include mechanisms of analgesia, clinical trial outcomes, and real-world patient experiences in conditions such as neuropathy, fibromyalgia, arthritis, and cancer-related pain. Presenters will cover dosage titration, long-term safety, and comparison with opioid therapy. Attendees will examine multimodal strategies combining cannabis with physical therapy, behavioral interventions, and complementary medicine.

This track investigates the emerging evidence for cannabinoids in managing neurological and psychiatric conditions. Presentations will cover epilepsy, multiple sclerosis, Parkinson’s disease, Tourette’s syndrome, PTSD, depression, and anxiety disorders. Emphasis will be placed on neuroprotective effects, synaptic modulation, and mood regulation via the ECS. Clinicians will gain insights into patient selection, risk-benefit analysis, and therapeutic monitoring. Key challenges, such as adverse psychiatric reactions, will also be addressed.

Extraction and formulation are critical for therapeutic consistency and safety. This session focuses on advanced technologies like supercritical CO₂ extraction, ethanol processing, and solventless methods. Experts will discuss purity, cannabinoid ratios, and terpene preservation during processing. The session also explores innovative formulations such as nanoemulsions, liposomal carriers, transdermal patches, and sublingual sprays. Attendees will learn about challenges in standardization, GMP compliance, and scalability in pharmaceutical development.

Cannabis in pediatric care is gaining attention, particularly for conditions like treatment-resistant epilepsy, autism spectrum disorders, and palliative care. This session reviews clinical findings, case studies, and the ethical frameworks needed when treating children with cannabis. Presenters will discuss long-term safety, appropriate dosing, and parental decision-making. Regulatory challenges, societal concerns, and physician responsibilities will also be explored. This is a must-attend track for clinicians working in pediatric and family medicine.

Navigating the complex legal landscape of medical cannabis requires in-depth knowledge of country-specific frameworks. This session offers a comparative analysis of global regulatory systems, from full legalization to restrictive medical use. Topics include licensing processes, import/export rules, quality control standards, and prescription models. Experts will discuss barriers to market entry, harmonization efforts, and opportunities for global collaboration. Policymakers, manufacturers, and clinicians will benefit from legal clarity and compliance strategies

Medical cannabis is increasingly integrated into oncology for symptom relief. This session covers evidence-based approaches to managing cancer-related pain, chemotherapy-induced nausea, appetite loss, anxiety, and insomnia. Presenters will examine real-world applications, safety concerns, and the integration of cannabis into standard oncology care. Early findings on cannabinoid anti-tumor effects and potential adjuvant therapy will be explored. Attendees will also learn about communication strategies with patients and families in palliative settings.

High-quality medicinal cannabis starts with optimal cultivation practices. This session covers plant genetics, strain selection, pest and disease control, and nutrient management. Experts will present strategies for both indoor and outdoor cultivation, highlighting environmental controls and yield optimization. Sustainable and organic farming practices, water conservation, and energy-efficient systems will be emphasized. Cultivators and manufacturers will gain insights into achieving consistent, contaminant-free, and potent cannabinoid profiles.

As cannabis-based medicine becomes mainstream, evidence from clinical trials is essential. This session addresses best practices in trial design, placebo controls, patient recruitment, and ethical approvals. Key trials in chronic pain, epilepsy, and psychiatric disorders will be presented, along with meta-analyses and observational studies. Attendees will learn how to interpret findings, translate them into practice, and contribute to evidence-based policy and treatment protocols. Regulatory expectations and publication strategies will also be discussed.

The endocannabinoid system (ECS) plays a central role in regulating physiological processes such as pain, inflammation, mood, appetite, and sleep. This session offers an in-depth exploration of ECS components, including endogenous cannabinoids (anandamide, 2-AG), cannabinoid receptors, and degradation enzymes. Presenters will examine ECS dysregulation in various disease states and how phytocannabinoids restore balance. Understanding ECS is key to optimizing cannabinoid therapy and predicting patient responses.

This track focuses on cannabis applications in women’s health issues such as endometriosis, PMS, menopause, sexual dysfunction, and anxiety. Clinicians and researchers will present gender-specific clinical data and explore hormonal interactions with the ECS. Discussions will include individualized dosing, female-led research, and addressing stigma in female patient populations. This session encourages inclusive approaches to care and highlights emerging clinical trials targeting women's health.

Older adults are among the fastest-growing groups of cannabis users. This session examines its therapeutic use for chronic pain, insomnia, neurodegenerative conditions, arthritis, and mood disorders in elderly populations. Presenters will discuss challenges including altered metabolism, polypharmacy, cognitive effects, and patient education. Emphasis will be placed on safe dosing, caregiver support, and enhancing quality of life through personalized cannabis regimens.

Effective treatment requires optimal delivery. This session covers various methods including inhalation, oral ingestion, sublingual drops, topicals, suppositories, and transdermal patches. Experts will explore the pros and cons of each system in terms of onset time, duration, patient adherence, and bioavailability. Topics also include product innovation, formulation stability, and regulatory implications. Case examples will illustrate how delivery influences patient outcomes and therapeutic success.

Cannabis shows both therapeutic potential and risk in mental health treatment. This session explores its use for PTSD, anxiety, depression, and substance use disorders, while also addressing adverse effects like psychosis and dependency. Presenters will share clinical experiences, screening tools, and risk mitigation strategies. Discussions will focus on evidence-based use, informed consent, and developing mental health protocols that safely incorporate cannabis therapy.

This session highlights the growing economic and therapeutic potential of industrial hemp. Topics include CBD production, sustainable textile manufacturing, biodegradable plastics, and hempcrete in construction. Experts will differentiate regulatory classifications between hemp and cannabis, emphasizing low-THC cultivars. Attendees will explore the full value chain—from farming to finished product—and understand hemp’s role in advancing environmental goals and expanding wellness markets.

As cannabis policy evolves, so do its implications for public health. This session analyzes the global shift from prohibition to regulation and its impact on community health, safety, and access. Presenters will discuss decriminalization, safe use education, harm reduction, and the social justice aspects of reform. Lessons from countries with legal frameworks will inform future directions. Attendees will also consider how research can guide effective, equitable policy.

The future of cannabis therapy lies in personalization. This session explores how genetics, epigenetics, and metabolic factors influence individual responses to cannabinoids. Topics include pharmacogenomics, biomarker development, and AI-driven treatment algorithms. Case examples will demonstrate how personalized cannabis care can improve outcomes and reduce side effects. Attendees will learn how to integrate this approach into clinical workflows.

This track brings together innovators and investors to explore the booming global cannabis economy. Topics include market analytics, product innovation, branding, consumer trends, and investment strategies. Startups will learn how to navigate licensing, compliance, and international expansion. Case studies will showcase success stories and pitfalls in cannabis entrepreneurship. The session offers a roadmap for scaling sustainably in a competitive and highly regulated space.

Cannabis is increasingly used alongside holistic therapies to support wellness. This session explores integrative care models that combine cannabis with practices such as acupuncture, nutrition, yoga, meditation, and naturopathy. Presenters will discuss synergy, clinical outcomes, and how to personalize care based on individual needs. Attendees will gain tools to implement patient-centered, whole-body healing strategies using cannabis as a complementary therapy.

This track provides an interactive platform for young scientists, graduate students, and early-career professionals to present innovative research in cannabis science and medicine. Presentations will be peer-reviewed, with awards for Best Poster and Best Oral Presentation. Participants will gain feedback from senior researchers and network with global experts. This forum encourages emerging talent, fosters mentorship, and highlights the next generation of cannabis leaders.